View on Pubmed.gov 16884686 | View on doi.org 10.1016/j.bbrc.... | View the free full text Full text
Identification and Herc5-mediated ISGylation of novel target proteins.
- Department of Biochemistry, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo 060-0812, Japan.
Abstract
ISG15, a protein containing two ubiquitin-like domains, is an interferon-stimulated gene product that functions in antiviral response and is conjugated to various cellular proteins (ISGylation) upon interferon stimulation. ISGylation occurs via a pathway similar to the pathway for ubiquitination that requires the sequential action of E1/E2/E3: the E1 (UBE1L), E2 (UbcH8), and E3 (Efp/Herc5) enzymes for ISGylation have been hitherto identified. In this study, we identified six novel candidate target proteins for ISGylation by a proteomic approach. Four candidate target proteins were demonstrated to be ISGylated in UBE1L- and UbcH8-dependent manners, and ISGylation of the respective target proteins was stimulated by Herc5. In addition, Herc5 was capable of binding with the respective target proteins. Thus, these results suggest that Herc5 functions as a general E3 ligase for protein ISGylation.
References
Cited by 80 citations (total)
Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review
HECT E3 ubiquitin ligases - emerging insights into their biological roles and disease relevance.
Electronic publication date June 22, 2021
Yaya Wang [...] Donald E Spratt et al.
Homologous to E6AP C-terminus (HECT) E3 ubiquitin ligases play a critical role in various cellular pathways, including but not limited...
Journal Article
USP16 is an ISG15 cross-reactive deubiquitinase that targets pro-ISG15 and ISGylated proteins involved in metabolism.
Electronic publication date December 11, 2023
Jin Gan [...] Aysegul Sapmaz et al.
Interferon-induced ubiquitin (Ub)-like modifier ISG15 covalently modifies host and viral proteins to restrict viral infections. Its function is counteracted by...
Conflict of interest statement
MeSH
- •
Specialties
- •
- •
Substances
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •